Kodiak Sciences (KOD) stock jumped after Zenkuda met primary endpoints in Phase 3 trial, showing 62.5% improvement rate vs. 3.3% for sham treatment.
Kodiak Sciences (KOD) stock rises after Zenkuda meets primary goals in GLOW2 Phase 3 trial, showing 62.5% patient improvement in diabetic retinopathy.
H&M shares dropped 6.6% Thursday after March sales guidance of 1% missed analyst expectations of 1.8%, overshadowing a strong Q1 profit performance.
CrowdStrike (CRWD) expands Intel and IBM partnerships at RSA 2026, enhancing AI security for endpoints and autonomous SOC operations. Analysts see 25% upside.
Wave Life Sciences (WVE) stock plunged 30% after Phase 1 obesity trial data revealed modest weight loss, sparking concerns about competitive viability.
Gold dropped 1.5% Thursday to $4,441/oz as U.S.-Iran diplomatic signals clash, oil tops $100, and markets abandon Fed rate cut hopes for 2024.
Chewy (CHWY) stock jumped 13% after issuing 2026 revenue guidance above estimates. AI savings and vet care growth drive investor optimism.
Space stocks surged as SpaceX IPO filing rumors emerged. AST SpaceMobile, Rocket Lab, and Firefly Aerospace rallied on news of a potential $1.75T valuation.
IBM (IBM) quantum computer successfully simulates magnetic crystal behavior, matching lab results in breakthrough previously thought impossible with today’s tech.
IBM (IBM) stock edges higher after quantum computer successfully simulated magnetic crystal KCuF3, matching neutron scattering results in major breakthrough.